Pulmatrix, Inc. (PULM) › Cash & EquivalentsPulmatrix, Inc. (PULM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $1.43M2014: $451.0K2015: $18.90M2016: $4.18M2017: $3.55M2018: $2.56M2019: $23.44M2020: $31.66M2021: $53.84M2022: $35.63M2023: $19.17M2024: $9.52M2025: $4.09M$4.09M2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.09M-57.1%2024$9.52M-50.3%2023$19.17M-46.2%2022$35.63M-33.8%2021$53.84M+70.1%2020$31.66M+35.1%2019$23.44M+814.6%2018$2.56M-27.8%2017$3.55M-15.1%2016$4.18M-77.9%2015$18.90M+4091.1%2014$451.0K-68.4%2013$1.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share